55703 Results for: "5-Fluor-o-anisaldehyd&amp"

Supplier: Apollo Scientific

5-Fluoro-o-anisaldehyde 99%

Supplier: Thermo Fisher Scientific

5-Fluoro-o-anisaldehyde ≥98%

Supplier: Thermo Fisher Scientific

4-Fluoro-o-anisaldehyde ≥98%

Supplier: Apollo Scientific

4-Fluoro-o-anisaldehyde 98%

Supplier: Apollo Scientific

2-Fluoro-m-anisaldehyde 99%

Supplier: Apollo Scientific

4-Fluoro-m-anisaldehyde 98%

Supplier: Apollo Scientific

6-Fluoro-m-anisaldehyde 98%

Supplier: Thermo Fisher Scientific

2-Fluoro-p-anisaldehyde ≥97%

Supplier: Apollo Scientific

3-Fluoro-p-anisaldehyde

Supplier: Apollo Scientific

5-Fluoro-m-anisaldehyde 97+%

Supplier: Apollo Scientific

3-Fluoro-o-anisaldehyde 98%

Supplier: Thermo Fisher Scientific

6-Fluoro-m-anisaldehyde ≥97%

Supplier: Apollo Scientific

6-Fluoro-o-anisaldehyde 98%

Supplier: Thermo Fisher Scientific

3-Fluoro-p-anisaldehyde ≥98%

Supplier: Apollo Scientific

2-Fluoro-p-anisaldehyde 95%

Supplier: Thermo Fisher Scientific

2-Fluoro-m-anisaldehyde 96%

Supplier: Thermo Fisher Scientific

4-Fluoro-m-anisaldehyde ≥98%

Supplier: ACTIVATE SCIENTIFIC

5-Fluoro-o-anisaldehyde

Supplier: ACTIVATE SCIENTIFIC

2-Fluoro-p-anisaldehyde

Supplier: ACTIVATE SCIENTIFIC

5-Fluoro-m-anisaldehyde

Supplier: ACTIVATE SCIENTIFIC

6-Fluoro-o-anisaldehyde

Supplier: Bioss

AMP deaminase plays a critical role in energy metabolism.Involvement in diseaseDefects in AMPD3 are the cause of adenosine monophosphate deaminase deficiency erythrocyte type (AMPDDE); also known as erythrocyte AMP deaminase deficiency. AMPDDE is a metabolic disorder due to lack of activity of the erythrocyte isoform of AMP deaminase. It is a clinically asymptomatic condition characterized by a 50% increase in steady-state levels of ATP in affected cells. Individuals with complete deficiency of erythrocyte AMP deaminase are healthy and have no hematologic disorders.

Supplier: Bioss

AMP deaminase plays a critical role in energy metabolism.Involvement in diseaseDefects in AMPD3 are the cause of adenosine monophosphate deaminase deficiency erythrocyte type (AMPDDE); also known as erythrocyte AMP deaminase deficiency. AMPDDE is a metabolic disorder due to lack of activity of the erythrocyte isoform of AMP deaminase. It is a clinically asymptomatic condition characterized by a 50% increase in steady-state levels of ATP in affected cells. Individuals with complete deficiency of erythrocyte AMP deaminase are healthy and have no hematologic disorders.

Supplier: Bioss

The protein encoded by this gene can hydrolyse substrates such as AMP-morpholidate, AMP-N-alanine methyl ester, AMP-alpha-acetyl lysine methyl ester, and AMP-NH2. The encoded protein interacts with these substrates via a histidine triad motif, which is part of the loop that binds to the substrate. This gene has been found to be a tumour suppressing gene. Several transcript variants, but only one of them protein-coding, have been found for this gene.

Supplier: Bioss

Probable inhibitory regulator of the Ras-cyclic AMP pathway.

Supplier: Bioss

Probable inhibitory regulator of the Ras-cyclic AMP pathway.

Supplier: Bioss

The protein encoded by this gene can hydrolyze substrates such as AMP-morpholidate, AMP-N-alanine methyl ester, AMP-alpha-acetyl lysine methyl ester, and AMP-NH2. The encoded protein interacts with these substrates via a histidine triad motif, which is part of the loop that binds to the substrate. This gene has been found to be a tumor suppressing gene. Several transcript variants, but only one of them protein-coding, have been found for this gene. [provided by RefSeq, Dec 2012].

Supplier: Bioss

AMP deaminase plays a critical role in energy metabolism.

Supplier: Bioss

AMP deaminase plays a critical role in energy metabolism.

Supplier: Bioss

Probable inhibitory regulator of the Ras-cyclic AMP pathway.